Jyothy Labs schedules one-on-one meeting with Magma Ventures

0 min read     Updated on 05 Jun 2026, 03:32 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Jyothy Labs Limited announced a one-on-one meeting with Magma Ventures on June 08, 2026, under Regulation 30 of SEBI regulations. The company confirmed no unpublished price sensitive information will be shared.

powered bylight_fuzz_icon
42199315

*this image is generated using AI for illustrative purposes only.

Jyothy Labs Limited has scheduled a one-on-one meeting with Magma Ventures on June 08, 2026. The interaction will provide the fund with an opportunity to engage directly with company representatives, though no unpublished price sensitive information (UPSI) will be disclosed during the session.

The meeting was intimated to the stock exchanges in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure noted that the schedule remains subject to change due to exigencies on the part of the investor or the company.

The following table outlines the details of the scheduled interaction:

Date of meeting Name of Fund/ Investor Type of Meeting
June 08, 2026 Magma Ventures One-on-One

Jyothy Labs stated that its latest Investor Presentation is accessible on its official website. The intimation was signed by Shreyas Parag Trivedi, Head – Legal & Company Secretary.

Historical Stock Returns for Jyothy Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
+0.27%-3.88%-25.16%-31.67%-41.25%+25.90%

What strategic insights might Jyothy Labs seek to gain from Magma Ventures during this interaction?

Could this meeting signal potential future collaborations or investment opportunities between the two entities?

How might the market react to the announcement of such investor engagements in the absence of UPSI disclosure?

Jyothy Labs sets June 25 deadline for dividend tax documents

2 min read     Updated on 28 May 2026, 08:29 AM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Jyothy Laboratories set a June 25, 2026 deadline for shareholders to submit documents for TDS deduction on the FY26 final dividend of ₹3.50 per share. The company specified tax rates ranging from NIL to 20% based on residency and documentation, warning that invalid PAN or Aadhaar details trigger a higher 20% TDS. Non-resident shareholders must submit specific forms to access treaty benefits.

powered bylight_fuzz_icon
41423866

*this image is generated using AI for illustrative purposes only.

Jyothy Laboratories has established a deadline of June 25, 2026, for shareholders to submit documentation required for the deduction of tax at source (TDS) on the recommended final dividend for FY26. The company's Board recommended a dividend of ₹3.50 per equity share, representing 350% of the face value of Re. 1, at a meeting held on May 4, 2026. The dividend payout is contingent upon approval at the upcoming 35th Annual General Meeting, with the record date to be announced later.

In accordance with the Income Tax Act, 2025, dividend income is taxable in the hands of shareholders, and the company is mandated to deduct TDS at the time of payment. The applicable tax rate varies based on the residential status of the shareholder and the validity of submitted documents. The company has communicated that failure to provide valid PAN or Aadhaar linkage details will result in a higher TDS rate of 20% under Section 397(2) of the Act.

Tax Rates and Documentation Requirements

The company outlined specific tax rates and documentation requirements for different categories of shareholders. For resident shareholders, the standard TDS rate is 10%. However, no tax will be deducted if the dividend income for FY26-27 does not exceed ₹10,000 or if the shareholder submits Form 121 declaring eligibility for exemption.

Category Tax Rate Key Conditions
Resident Shareholder 10% Standard rate applies.
Resident Shareholder (Exempt) NIL Dividend income ≤ ₹10,000 or valid Form 121 submitted.
Resident without PAN/Invalid PAN 20% Applicable if PAN is invalid or not linked with Aadhaar.

Specific entities such as insurance companies, corporations established under Central Acts, mutual funds, and Alternative Investment Funds (AIF) are eligible for NIL or lower tax rates upon submission of self-declarations and documentary evidence proving exemption under relevant sections of the Act.

Non-Resident Shareholder Obligations

For non-resident shareholders, including Foreign Institutional Investors (FIIs) and Foreign Portfolio Investors (FPIs), the TDS rate is set at 20% or the applicable tax treaty rate, whichever is lower. To avail of the lower treaty rate, shareholders must submit a Tax Residency Certificate (TRC), Form 41 filed online, and a self-declaration confirming non-existence of permanent establishment in India.

If the requisite documents are not submitted by the deadline, TDS will be deducted at the statutory rate of 20% plus surcharge and cess. The company clarified that it is not obligated to apply treaty rates if documentation is incomplete. Shareholders must send forms to the Registrar via email or update details online by June 25, 2026. No communication regarding tax determination will be accepted after this date.

Historical Stock Returns for Jyothy Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
+0.27%-3.88%-25.16%-31.67%-41.25%+25.90%

How will the strict 20% TDS penalty for invalid PANs impact retail shareholder participation ahead of the record date?

What effect will the 350% dividend payout have on Jyothy Laboratories' free cash flow and capital allocation plans for FY27?

Could the administrative burden of submitting Tax Residency Certificates deter FPI investment in the stock leading up to the deadline?

More News on Jyothy Laboratories

1 Year Returns:-41.25%